![5000100-flag[1].jpg](https://cdn.european-virus-archive.com/sites/default/files/5000100-flag%5B1%5D.jpg)
The best way to get viral material within the Scientific Community. Browse our viruses and derived products from the EVAg Portal.
A unique biological resource in the field of virology, readily available online. Users may benefit from special funding to access to products of interest, do not hesitate to apply.
An international group of 25 laboratories, including 16 EU member state institutions and 9 non-EU institutions, that represent an extensive range of virological disciplines.
An open entity aiming at developing synergies and complementary capabilities in such a way as to offer an improved access to researchers.
The quality of viruses and derived products is a key consideration when our products are to be made available. Improvements on quality process will be addressed during the project.
EVAg generates and distributes globally diagnostic materials and protocols in the event of epidemiological emergencies.
Focused on the creation of new tools, techniques and concepts to develop the infrastructure and to provide easier and less expensive access to virological materials.
A user-friendly web Portal with a continuously increasing number of viruses and derived products. Start here...
The EVAg initiative will increase competitiveness and, provides for a strong interaction with industry and a promising foundation for the innovation process between academia and industry.
- The European Commission -
The initiative has an important social impact with particular emphasis on human disease.
- The European Commission -
The quality of the installations cooperating in this consortium is excellent, representing some of the best available infrastructures across the EU and world-wide.
- The European Commission -
EVA-GLOBAL is co-orgaising this online course on biobanking ! Registration is ON until the 2nd of March. @institutpasteur'>@institutpasteur'>https://t.co/1iLuETt6zu @institutpasteur'>@institutpasteur @EVAg_EU
**IMPORTANT** Due to the very high number of demands through the EVAG catalogue, may we ask you to CAREFULLY READ instructions for the ordering procedure. Deviation from our emergency procedure will result in delays for your order. Thank you very much. Your dedicated EVA team https://t.co/pO2311iJcS
**Three 2019-nCoV strains FREE OF CHARGE WORLDWIDE** Germany ex China https://t.co/CrcHC4mc9z France ex China https://t.co/zSj8f4HQsO Italy ex China https://t.co/3mqhm4IUZw And diagnostics products of course: @c_drosten'>@c_drosten'>https://t.co/2kkRFzG1ms @c_drosten'>@c_drosten @institutpasteur @INMISpallanzani https://t.co/08lto0C2Vw
Dr Prat presenting the role the European Virus Archive Global is playing during this 2019-nCoV outbreak @VirusesMDPI #Virology2020 https://t.co/MTiy8fF57a
Institut Pasteur Paris have also added a 2019-nCoV strain to the EVAG catalogue: https://t.co/xK6hCa9rL4
And with rapid distribution :) ! https://t.co/4xmyGbauim
And don't forget, if you prefer human interaction, we have a booth right now at the #Viruses2020 @VirusesMDPI conference in Barcelona !
@Thushan_deSilva @florian_krammer @EU_H2020 No, we have an emergency procedure for 2019-nCoV products. Due to the very large number of requests though, the delivery time is usually one week (sometimes less if all the paperwork is ready for import).
PURPOSE OF THIS COURSE: The purpose of this course is to enhance transfer of knowledge on biobanking by providing an online and pratical training. The... read more
Given the epidemiological situation concerning the new coronavirus isolated in Wuhan, China, a simplified and quicker procedure has been put in place ... read more
A one-day workshop was organised by our EVAg partner Animal and Plant Health Agency, APHA on the 15th of October, 2016. The aim of this workshop was t... read more
We at Luminex were sincerely appreciative of your willingness to work with us during the development of our xMAP® MultiFLEX™ Zika RNA Assay. The materials from EVAg supported our FDA submission, which is now authorized for emergency use.
Sarah M. Dunlap, PhDDirector, Clinical Operations - Luminex Corporation
We received high quality products at no cost. It helped us a lot in achieving our project. Thank you!
John UserR & D - Laboratory
